News Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a...
News OrisDX Wins 2022 Edward L. Kaplan, ’71, New Venture Challenge with Saliva Test to Diagnose Oral Cancers UPDATE: The investment totals have been updated to reflect additional investment made in the days following the winner announcement. A startup developing saliva-based diagnostics to screen for oral cancers and...
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
News Cancer Detection, Oil Spill Cleanup, Quantum Computing, and a New Medical Device: Meet the Spring 2022 Innovation Fund Finalists Four teams have been selected as finalists for the George Shultz Innovation Fund spring 2022 investment cycle – bringing to the forefront solutions for scaling quantum computers, sustainably cleaning oil...
News 3 Startups Awarded $200,000 Each to Build Out Teams, Launch Novel Products Flow Medical, Lismikro, and OrisDX each have been awarded a $200,000 co-investment from the George Shultz Innovation Fund to further develop their technologies. Managed by the Polsky Center for Entrepreneurship...
News Debate it Forward Takes Home Top Prize and $60,000 at the 2019 John Edwardson, ’72, Social New Venture Challenge Finals Winners of the ninth annual SNVC received a total of $140,000 in venture funding, the most prize money ever awarded at the startup competition.